Score Breakdown
Offering Ability
60
Cash Runway—
Float Risk
87
Warrant Exposure
40
Convertible Debt
15
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.93 approaching $1 threshold
Market Data
Market Cap$47.09M
Shares Outstanding27.70M
Float2.85M
Cash$2.79M
Debt$8.12M
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest472
Days to Cover1.0
% of Float0.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2022-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual IDXG Dilution Snapshot
Interpace Biosciences, Inc. (IDXG) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for IDXG: xbrl on 2022-12-31.
- Score coverage note: Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.